Tenon Medical, Inc. (TNON)

Market Cap	2.76M
Revenue (ttm)	2.93M
Net Income (ttm)	-15.58M
Shares Out	3.73M
EPS (ttm)	-8.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,790
Open	0.773
Previous Close	0.736
Day's Range	0.740 - 0.784
52-Week Range	0.710 - 23.000
Beta	n/a
Analysts	Buy
Price Target	3.00 (+305.41%)
Earnings Date	May 7, 2024

About TNON

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquar...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 27, 2022
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: TNON

Financial Performance

In 2023, Tenon Medical's revenue was $2.93 million, an increase of 323.73% compared to the previous year's $691,000. Losses were -$15.58 million, -17.63% less than in 2022.

Analyst Forecast

According to one analyst, the rating for TNON stock is "Buy" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(305.41% upside)

Analyst Consensus: Buy